Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Nomi Biotech

Nomi Biotech
2018 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$264K LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of nutraceuticals intended to combine nutritional values and characteristics of pharmaceuticals. The company specializes in the design and production of preventive nutraceuticals to support the human body in the fight against the negative effects of alcohol consumption or sugar excess common in food products thereby helping protect consumers from long term negative effects of consuming alcohol such as cancer, Alzheimer's disease, and oxidative stress.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • YouNick Technology Park
  • Ul. Krzemowa 1, Złotniki
  • Suchy Las, 62-002
  • Poland

+48 530 000 000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Nomi Biotech’s full profile, request a free trial.

Nomi Biotech Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 29-Jul-2019 $264K 00000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Nomi Biotech Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Black Pearls VC Venture Capital Minority 000 0000 000000 0

Nomi Biotech Executive Team (4)

Name Title Board
Seat
Contact
Info
Marcin Jaskuła Co-Founder, Chief Executive Officer, Chairman & President
Kohei Yagi Ph.D Co-Founder, Chief Technology Officer & Deputy Chairman
Michał Żukowski Co-Founder
Jakub Urbański Ph.D Co-Founder & Chief Scientific Officer